• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Nov;95(11):e29274.
doi: 10.1002/jmv.29274. Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease

Yotaro Kondo[SUP] 1 [/SUP], Yoshiki Kawamura[SUP] 1 2 [/SUP], Fumihiko Hattori[SUP] 3 4 [/SUP], Hidetaka Nakai[SUP] 4 [/SUP], Kazuyoshi Saito[SUP] 1 [/SUP], Daijiro Suzuki[SUP] 1 2 [/SUP], Kei Kozawa[SUP] 1 [/SUP], Tetsushi Yoshikawa[SUP] 1 [/SUP]



Affiliations
Abstract

Multisystem inflammatory syndrome in children (MIS-C) was reported as a severe complication of coronavirus disease 2019; an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and was suggested to be associated with Kawasaki disease (KD) in terms of severe systemic inflammation and mucocutaneous symptoms. Because severe gastrointestinal symptoms and systemic shock are more frequently observed with MIS-C, patients with mild MIS-C might have been diagnosed with KD. In this study, titers of IgG antibodies against the SARS-CoV-2 S (S-IgG) and N proteins (N-IgG) were measured in 99 serum samples collected from patients with KD treated between January 2020 and December 2021 to evaluate the relationship between KD and SARS-CoV-2 infection. S-IgG were detected in only one patient out of 99 patients. This patient had coronavirus disease 2019 (COVID-19) 10 months before KD onset, and was unlikely MIS-C. According to characters of S-IgG and N-IgG, the patients was unlikely infected with SARS-CoV-2 just before the onset of KD. In addition to this study, the 26th Nationwide Survey and previous studies showed an association between KD and SARS-CoV-2 to be unlikely. In conclusion, SARS-CoV-2 infection was not observed in patients with KD until Delta predominance in Japan by the method of detecting SARS-CoV-2 IgG.

Keywords: Kawasaki disease; antibody; coronavirus disease 2019; enzyme-linked immunosorbent assay; severe acute respiratory syndrome coronavirus 2.

 
Back
Top Bottom